发明名称 INDOLINE OR TETRAHYDROQUINOLINE DERIVATIVE
摘要 PROBLEM TO BE SOLVED: To obtain the subject new compound comprising a specific indoline compound and having excellent inhibitory actions on activated blood coagulation factor X and useful as a therapeutic or a prophylactic agent for blood coagulating diseases. SOLUTION: This compound is represented by formula I (R1 is H, a 1-6C alkyl or the like; R2 is a 3-10C cycloalkyl or the like; R3 and R4 are each H, a halogen or the like; A is a single bond a 1-4C alkylene or the like; n is 1 or 2), e.g. 2-(7-amidinonaphthalen-2-yl)-1-ethanesulfonyl-5-(piperidin-3-yloxy)ind oline dihydrochloride. The compound represented by formula I is obtained by reacting a compound represented by formula II with alcohols in the presence of an acid (e.g. hydrogen chloride) in an inert solvent (e.g. dichloromethane), preferably at 0-50 deg.C for 1-15 h, providing an iminoether compound and then carrying out an ammonolysis of the resultant iminoether compound in the presence of ammonium ion in an inert solvent at pH 7-9, preferably at 0-50 deg.C for 1-15 h.
申请公布号 JP2001072662(A) 申请公布日期 2001.03.21
申请号 JP20000197444 申请日期 2000.06.30
申请人 SANKYO CO LTD 发明人 FUJIMOTO KOICHI;ASAI FUMITOSHI;TANAKA NAOKI;MATSUHASHI HAYAO;SUGIDACHI KAZUHIRO;TANIMOTO TATSUO
分类号 C07D401/04;A61K31/403;A61K31/4035;A61K31/404;A61K31/41;A61K31/4427;A61K31/454;A61K31/4545;A61K31/496;A61K31/5375;A61P7/02;A61P9/00;A61P9/10;C07D209/18;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D403/14;C07D413/12;(IPC1-7):C07D209/18 主分类号 C07D401/04
代理机构 代理人
主权项
地址